CA-074 Me: A Selective Cathepsin B Inhibitor for Dissecting Lysosomal Pathways

Executive Summary: CA-074 Me is a methyl ester derivative of CA-074 and serves as a potent, membrane-permeable cathepsin B inhibitor with an IC50 of 36.3 nM, enabling precise inhibition of intracellular cathepsin B activity (APExBIO product information). Recent studies reveal that cathepsin B release following lysosomal membrane permeabilization is a central event in regulated cell death such as necroptosis (Liu et al., 2023). CA-074 Me shows high selectivity for cathepsin B but can also partially inhibit cathepsin L under reducing conditions. Its solubility profile (≥19.88 mg/mL in DMSO, ≥51.5 mg/mL in ethanol with sonication) supports high-sensitivity cell biology workflows. CA-074 Me is a gold standard for apoptosis, lysosomal enzyme inhibition, and inflammation research, and is supplied by APExBIO under SKU A8239.

Biological Rationale

Cathepsin B is a lysosomal cysteine protease implicated in regulated cell death pathways, including apoptosis and necroptosis. During necroptosis, lysosomal membrane permeabilization (LMP) triggers the release of cathepsin B into the cytosol, where it cleaves essential proteins, amplifying cell death signals (Liu et al., 2023). Dysregulation of cathepsin B activity is associated with inflammation, organ injury, and cancer. Selective inhibition of cathepsin B is essential to delineate its causal roles in these processes (CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal...). This article extends existing summaries by providing quantitative benchmarks and clarifies off-target limitations in cell-based and animal model contexts.

Mechanism of Action of CA-074 Me (Cathepsin B inhibitor)

CA-074 Me acts as a competitive, highly selective, and reversible inhibitor of cathepsin B, inhibiting its proteolytic activity by binding to the active site. The methyl ester modification enhances cell permeability, allowing intracellular targeting (APExBIO). CA-074 Me blocks the downstream effects of cathepsin B release following LMP, mitigating cell death in necroptosis and related pathways. Under reducing conditions (e.g., presence of DTT or GSH), CA-074 Me can also partially inhibit cathepsin L (>90% inhibition after pre-incubation), which is a limitation for interpreting results in highly reductive cellular environments. The compound is insoluble in water but dissolves readily in DMSO and ethanol, facilitating use in standard cell culture and biochemical assays.

Evidence & Benchmarks

• CA-074 Me inhibits purified human cathepsin B with an IC50 of 36.3 nM under standard assay conditions (APExBIO product page).
• Lysosomal membrane permeabilization during necroptosis leads to cytosolic release of cathepsin B, and chemical inhibition with CA-074 Me protects cells from necroptotic death (Liu et al., 2023).
• CA-074 Me demonstrates >90% inhibition of cathepsin L only under reducing conditions, requiring caution in data interpretation in such environments (APExBIO).
• In animal models, CA-074 Me attenuates TNF-α-induced liver injury by reducing cathepsin B activity and associated apoptosis (CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal...).
• The compound is highly soluble in DMSO (≥19.88 mg/mL) and in ethanol when sonicated (≥51.5 mg/mL), but insoluble in water, requiring appropriate solvent selection for experimental workflows (product data).

Applications, Limits & Misconceptions

CA-074 Me is widely used in apoptosis assays, lysosomal enzyme inhibition studies, and models of TNF-α-induced liver injury. It is a reference tool in inflammation research and for dissecting necroptosis pathways, as supported by recent mechanistic studies (MLKL-Induced Lysosomal Permeabilization Drives Necroptosis). This article clarifies the compound’s selectivity profile and use parameters, updating and extending prior reviews by providing quantitative solubility and inhibition data.

Common Pitfalls or Misconceptions

• CA-074 Me is not selective for cathepsin B under highly reducing conditions, as it partially inhibits cathepsin L in such settings.
• The compound is insoluble in water; attempts to dissolve it in aqueous buffers will result in precipitation and loss of activity.
• Solutions of CA-074 Me are not stable for long-term storage and should be prepared fresh for each experiment.
• Interpretation of results in complex in vivo models must account for possible off-target effects, particularly under conditions with elevated reducing agents.
• CA-074 Me does not inhibit other cathepsins (e.g., D, S, or K) at standard concentrations used in cell culture or animal models.

Workflow Integration & Parameters

• Dissolution: Dissolve CA-074 Me in DMSO (≥19.88 mg/mL) or ethanol (≥51.5 mg/mL with ultrasonic treatment); avoid water.
• Stock Preparation: Prepare stock solutions immediately before use; do not store solutions for more than a few hours at 4°C.
• Storage: Store solid compound at -20°C, protected from light and moisture.
• Concentration Range: Use 10–100 nM for cell-based assays, adjusting based on species and cell type sensitivity (CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal...).
• Reductive Conditions: For experiments requiring reducing agents (e.g., DTT, GSH), interpret results with caution due to partial cathepsin L inhibition.
• Apoptosis Assays: Add CA-074 Me prior to or simultaneously with cell death inducers; incubation times of 30–120 min are standard.

Conclusion & Outlook

CA-074 Me is a well-characterized, highly selective cathepsin B inhibitor that empowers researchers to dissect lysosomal pathways and regulated cell death, as evidenced by robust in vitro and in vivo benchmarks (Liu et al., 2023). Its effectiveness in apoptosis assays and TNF-α-induced liver injury models, coupled with a clear selectivity and solubility profile, make it a first-choice tool for mechanistic studies. The growing insights into the role of lysosomal membrane permeabilization and cathepsin B in necroptosis highlight the compound’s continued relevance, as summarized in thought-leadership and review articles (Unraveling Lysosomal Cathepsin B: Strategic Pathways). Researchers should remain aware of its limitations under reducing conditions and solubility constraints. APExBIO continues to supply CA-074 Me (SKU A8239) to support high-reproducibility research in cell death and inflammation biology.